Genomic Analysis

Selected news for the healthcare topic - Genomic Analysis, collected since 10/2017. There are 1.4K items in the archive. This healthcare topic shares news with Genomics, COVID-19, Coronavirus, Oncology and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/16/2022 Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling. Physicians Weekly ... negative breast cancer cells, the reduction in expression B2AR and MOR by genetic and pharmacological tools leads to a less aggressive phenotype of triple-negative breast cancer cells in vitro and in animal xenografts. Genomic analysis indicates the glycogen synthase kinase 3 (GSK3) pathway as a possible candidate messenger system involved in B2AR and MOR cross talk. GSK3 inactivation in MDA-MB-231 and MDA-MB-468 cells induced similar ...
5/10/2022 GeneCentric to Present Initial Clinicogenomic Results from the GARNER High-Risk Non-Muscle Invasive Bladder Cancer Real-World Study Business Wire ... Institute (EMC), Janssen Research & Development, LLC (Janssen) and GeneCentric Therapeutics. The collaboration, led at EMC by Tahlita Zuiverloon, MD, PhD, Principal Investigator at the Erasmus MC Urothelial Cancer Research Group (EUCRG), involves retrospective longitudinal, genomic analysis of samples from a cohort of almost 600 NMIBC patients who underwent surgery and adjuvant BCG treatment.“The initial results from the GARNER Study provide a comprehensive picture of FGFR alteration frequency and other ...
5/10/2022 GeneCentric to Present Initial Clinicogenomic Results from the GARNER High-Risk Non-Muscle Invasive Bladder Cancer Real-World Study | Business Wire Business Wire ... Institute (EMC), Janssen Research & Development, LLC (Janssen) and GeneCentric Therapeutics. The collaboration, led at EMC by Tahlita Zuiverloon, MD, PhD, Principal Investigator at the Erasmus MC Urothelial Cancer Research Group (EUCRG), involves retrospective longitudinal, genomic analysis of samples from a cohort of almost 600 NMIBC patients who underwent surgery and adjuvant BCG treatment.“The initial results from the GARNER Study provide a comprehensive picture of FGFR alteration frequency and other ...
5/5/2022 Single-cell genomic analysis of triple-negative breast cancer fibroblasts uncovers evolutionarily conserved features and potential therapeutic targets biorxiv.org New Results Single-cell genomic analysis of triple-negative breast cancer fibroblasts uncovers evolutionarily conserved features and potential therapeutic targets Ana Paula Delgado , Alice Nemajerova , Jinyu Li , Natalia Marchenko , Jonathan Preall , Ute M Moll , Mikala Egeblad , Scott Powers doi: https://doi.org/10.1101/2022.05.05.490693 Preview PDF Abstract To explore cancer associated fibroblasts (CAFs) in triple-negative breast cancers (TNBC), we performed scRNA-seq analysis of fibroblasts from murine and human TNBCs. We ...
5/2/2022 dPCR and qPCR market : Opportunities, Structures, Drivers and Competitive Landscape PRSync ... the largest share of the global dPCR and qPCR market, followed by North America. The large share of the North American Digital PCR Market is attributed to the increased adoption of innovative and novel genomic analysis products (including advanced qPCR and dPCR products), availability of RD funding for genomic research (coupled with the robust research infrastructure in the region), expanding use of PCR techniques in clinical diagnostics forensics, and early ...
4/28/2022 Allelica Joins Forces with Leader in Genotyping Technology to Enable Polygenic Risk Score PR Newswire World leader in genomic analysis is licensing Allelica's software to provide its customers with the industry's most advanced tools for polygenic risk score analysis research and reportingNEW YORK , April 28, Allelica , a leading genomics software company that develops digital tools to develop, validate and calculate PRS for common diseases, announced that Illumina , a leading developer and manufacturer of life-science tools and integrated systems for large-scale analysis of ...
4/27/2022 BioMarin Announces Record Revenues in First Quarter 2022 Yahoo News ... over 5 years ago reported a salivary gland mass in late 2021. The event was reported as unrelated to valoctocogene roxaparvovec by the investigator. The subject was successfully treated, and the Company conducted a genomic analysis from a tissue sample containing the mass. Today, BioMarin announced that the findings from the completed analysis showed a comparable pattern of integration between healthy and tumor containing tissues, with no evidence emerging that ...
4/27/2022 BioMarin Announces Record Revenues in First Quarter 2022 PR Newswire ... Hemophilia A Under Review in Europe with Committee for Medicinal Products for Human Use (CHMP) Opinion Anticipated Mid-year 2022; Re-submission of the Biologics License Application (BLA) in the U.S. Planned in June Genomic Analysis Complete from Phase 2 Subject Treated with Valoctocogene Roxaparvovec in 2016; Findings do not Identify a Contribution from Vector Integration to the Previously Announced Adverse Event Financial Highlights (in millions of U.S. dollars, except ...
4/23/2022 MUC1 triggers lineage plasticity of Her2 positive mammary tumors Nature ... overexpressing both Her2 and MUC1 cytoplasmic domain (MUC1-CD) to investigate their interaction in mammary carcinogenesis. Coexpression of Her2 and MUC1-CD conferred a growth advantage and promoted the development of spontaneous mammary tumors. Genomic analysis revealed that enforced expression of MUC1-CD and Her2 induces mammary tumor lineage plasticity, which is supported by gene reprogramming and mammary stem cell enrichment. Through gain- and loss-of-function strategies, we show ...
4/21/2022 Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer Nature AbstractGastric cancer (GC) is the second cause of cancer-related death and metastasis is an important cause of death. Considering difficulties in searching for metastatic driver mutations, we tried a novel strategy here. We conducted an integrative genomic analysis on GC and identified early drivers lead to metastasis. Whole-exome sequencing (WES), transcriptomes sequencing and targeted-exome sequencing (TES) were performed on tumors and matched normal tissues from 432 ...
4/14/2022 DermTech Announces Release Date for First-Quarter 2022 Financial Results Business Wire ... medicine, precision dermatology, enabled by our non-invasive skin genomics platform. DermTech’s mission is to improve the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory ...
4/13/2022 Genomic analysis of population structure, antimicrobial resistance, and virulent factors of methicillin-resistant Macrococcus caseolyticus in global lineages biorxiv.org New Results Genomic analysis of population structure, antimicrobial resistance, and virulent factors of methicillin-resistant Macrococcus caseolyticus in global lineages Yu Zhang , Shengyi Min , Yuxuan Sun , Jiaquan Ye , Zhemin Zhou , View ORCID Profile Heng Li doi: https://doi.org/10.1101/2022.04.12.488041 Preview PDF Abstract Macrococcus caseolyticus is an opportunistic pathogen frequently detected in dairy products as well as veterinary infections. The present study examined the population structure, antimicrobial resistance, and virulent factors ...
4/10/2022 Oracle Cloud and Sentieon DNAseq enable processing of 30X WGS samples from FASTQ to VCF in about an hour and less than $1 in on-demand costs | by David Chen, Ph.D. | Apr, 2022 | Medium Medium ... they can be flexibly configured with CPU core count and amount of memory, allowing you to customize resource usage to your application. In contrast, bare metal shapes are designed for resource-hungry workloads. The genomic analysis studied here have lower resource requirements, so we excluded bare metal shapes in this study because they’re unlikely to provide an optimal cost-performance configuration.Benchmarked test cases The whole genome sequencing (WGS ...
4/9/2022 Genomic analysis of XE variant sample from Guj underway: Health ministry - Opera News dailyadvent.com His wife was accompanying him.According to the results of his samples genome sequencing received on Friday, he is found to have been infected with the new mutant XE , a sub-variant of Omicron, he said.The man had visited Vadodara due to some work and stayed at a hotel. The genomic analysis of the...Read Full Story ...
4/9/2022 Genomic analysis of XE variant sample from Gujarat underway: Health ministry - The Economic Times indiatimes.com The genomic analysis of the COVID-19 XE variant sample from Gujarat is still underway and results are expected soon, Union health ministry sources said on Saturday. The World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID-19 strain so far. The XE variant is a combination or ...
4/9/2022 Genomic analysis of XE variant sample from Gujarat underway: Health ministry orissapost.com New Delhi: The genomic analysis of the COVID-19 XE variant sample from Gujarat is still underway and results are expected soon, Union health ministry sources said Saturday.The World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID-19 strain so far.The XE variant is a combination ...
4/9/2022 Genomic analysis of XE variant sample from Guj underway: Health ministry financialexpress.com The genomic analysis of the COVID-19 XE variant sample from Gujarat is still underway and results are expected soon, Union health ministry sources said on Saturday.The World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID-19 strain so far. The XE variant is a combination or ...
4/9/2022 Genomic analysis of XE variant sample from Guj underway: Health ministry gadgetclock.com Genomic analysis of XE variant sample from Guj underway: Health ministryThe genomic analysis of the COVID-19 XE variant sample from Gujarat is still underway and results are expected soon, Union health ministry sources said on Saturday.The World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID ...
4/9/2022 Genomic analysis of XE variant sample from Gujarat underway: Health ministry indiantodayonline.com Gujarat reported its first case of the XE variant after a man from Mumbai tested positive for COVID-19.Genomic analysis of XE variant sample from Gujarat underway: Health ministryGujarat reported its first case of the XE variant after a man from Mumbai tested positive for COVID-19 ...
4/9/2022 Genomic Analysis Of XE Variant Sample From Guj Underway: Health Ministry - WorldNewsEra worldnewsera.com r\nThe genomic analysis of the COVID-19 XE variant sample from Gujarat is still underway and results are expected soon, Union health ministry sources said on Saturday.\n\n\nThe World Health Organisation (WHO) has issued a warning against XE, a new variant of Omicron first detected in the UK, and suggested that it could be more transmissible than any COVID-19 strain so far. The XE variant is ...